LivaNova

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LivaNova and other ETFs, options, and stocks.

About LIVN

LivaNova Plc is a global medical technology company, which engages in the development and delivery of therapeutic solutions for the benefit of patients, healthcare professionals, and healthcare systems. It operates through the following segments: Cardiopulmonary, Neuromodulation, and Advanced Circulatory Support (ACS). 

CEO
Vladimir A. Makatsaria
CEOVladimir A. Makatsaria
Employees
2,900
Employees2,900
Headquarters
London, Greater London
HeadquartersLondon, Greater London
Founded
2015
Founded2015
Employees
2,900
Employees2,900

LIVN Key Statistics

Market cap
3.44B
Market cap3.44B
Price-Earnings ratio
-15.73
Price-Earnings ratio-15.73
Dividend yield
Dividend yield
Average volume
592.49K
Average volume592.49K
High today
High today
Low today
Low today
Open price
$63.41
Open price$63.41
Volume
0.00
Volume0.00
52 Week high
$65.57
52 Week high$65.57
52 Week low
$32.48
52 Week low$32.48

Stock Snapshot

LivaNova(LIVN) stock is priced at $63.08, giving the company a market capitalization of 3.44B. It carries a P/E multiple of -15.73.

On 2025-12-26, LivaNova(LIVN) stock opened at $63.41, reached a high of —, and a low of —.

The LivaNova(LIVN)'s current trading volume is 0, compared to an average daily volume of 592.49K.

During the past year, LivaNova(LIVN) stock moved between $32.48 at its lowest and $65.57 at its peak.

During the past year, LivaNova(LIVN) stock moved between $32.48 at its lowest and $65.57 at its peak.

LIVN News

Simply Wall St 3d
Is Optimism Around aura6000 and Margin Upside Altering The Investment Case For LivaNova?

Earlier this month, KeyBanc analyst Brett Fishbin initiated coverage on LivaNova with an Overweight rating, highlighting underappreciated performance momentum a...

Is Optimism Around aura6000 and Margin Upside Altering The Investment Case For LivaNova?
Simply Wall St 4d
LivaNova: Reassessing Valuation After KeyBanc’s Overweight Initiation and Growth Outlook

KeyBanc just kicked off coverage on LivaNova (LIVN) with an Overweight call, highlighting what it sees as underappreciated growth from capital equipment cycles,...

LivaNova: Reassessing Valuation After KeyBanc’s Overweight Initiation and Growth Outlook

Analyst ratings

73%

of 11 ratings
Buy
72.7%
Hold
27.3%
Sell
0%

People also own

Based on the portfolios of people who own LIVN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.